RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES

Clinical trials for RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New RNA therapy tested for Tough-to-Treat autoimmune conditions

Disease control Recruiting now

This early-stage study is testing the safety and initial effectiveness of a new treatment called RXIM002 for adults with severe autoimmune diseases that have returned or not improved with standard therapies. RXIM002 is an experimental RNA-based therapy designed to modify a patien…

Matched conditions: RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES

Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES

Get alerted when new RELAPSED/REFRACTORY B CELL-MEDIATED AUTOIMMUNE DISEASES trials appear

New RNA therapy tested for Tough-to-Treat autoimmune conditions